← Back
$LXRX All transactions

LEXICON PHARMACEUTICALS, INC.

A

$ Value

$2.7M

Shares

41,290

Price

$65

Filed

Feb 19

Insider

Name

Artal Participations S.a r.l.

Title

CIK

0002048403

Roles

Director 10% Owner

Transaction Details

Transaction Date

2026-02-17

Code

A

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

408,435

Footnotes

Pursuant to that certain preferred stock purchase agreement (the "Purchase Agreement") with the Issuer, dated as of January 29, 2026, in connection with the underwriter's partial exercise of their option to purchase additional shares of Issuer common stock par value $0.001 per share (the "Common Stock") in an underwritten public offering, Artal Participations S.a r.l. purchased an additional 41,289.58 shares of Issuer Series B Convertible Preferred Stock, par value $0.01 per share (the "Preferred Stock") at a price of $65.00 per share. Each share of Preferred Stock will automatically convert into 50 shares of Common Stock upon receipt of shareholder approval and the satisfaction of certain other conditions; however, absent the satisfaction of such conditions, the shares are not convertible. | These securities are directly held by Artal Participations S.a r.l. | The sole shareholder of Artal Participations S.a r.l. is Artal International S.C.A. The managing partner of Artal International S.C.A. is Artal International Management S.A. The sole stockholder of Artal International Management S.A. is Artal Group S.A. The parent company of Artal Group S.A. is Westend S.A. The majority stockholder of Westend S.A. is Stichting Administratiekantoor Westend (the "Stichting"). Mr. Amaury Wittouck is the sole member of the board of the Stichting. | Each of the Reporting Persons (other than to the extent it directly holds securities reported herein) disclaims beneficial ownership of the securities held by the other Reporting Persons, except to the extent of such Reporting Person's pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), each of the Reporting Persons (other than to the extent it directly holds securities reported herein) states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 of the Exchange Act or for any other purpose.

Filing Info

Accession No.

0001193125-26-059599

Form Type

4

Issuer CIK

0001062822

Artal Participations S.a r.l.'s History

Date Ticker Type Value
2026-02-17 LXRX A $2.7M

Other Insiders at LXRX (90d)

Insider Bought Sold Last
Invus Global Management, LLC $2.0M 2026-02-02
DEBBANE RAYMOND $723K 2026-02-25
Coiante Scott M
SVP, Chief Financial Officer
2026-02-28
Crum Brian T
SVP, General Counsel & Secr.
2026-02-28
DeFrancesco Lisa
SVP, IR and Corp Comm
2026-02-28
Granowitz Craig B
SVP, Chief Medical Officer
2026-02-28
McDermott Wendy
SVP, Human Resources
2026-02-28
Exton Michael
Chief Executive Officer
2026-02-28
Gopinathan Suma
SVP, Discovery
2026-02-28
Martens Rachel Yap
SVP, Partnerships & Corp Strat
2026-02-28